Treatment of Postmenopausal Facial Hirsutism
For a postmenopausal woman with facial hirsutism, start with laser hair removal (photoepilation) combined with topical eflornithine cream 13.9% (Vaniqa) for optimal cosmetic results, while simultaneously evaluating for underlying androgen excess that may require specific medical or surgical intervention.
Initial Evaluation Priority
Before initiating treatment, you must determine the severity and acuity of presentation:
- Sudden onset or rapid progression = red flag requiring immediate workup for androgen-secreting tumor 1, 2
- Virilization features (voice deepening, clitoromegaly, severe acne) = urgent evaluation needed 2
- Gradual onset mild-to-moderate hirsutism = can proceed with cosmetic treatment while evaluating
Key Diagnostic Steps
Measure early morning total testosterone as the initial test 3. If testosterone is >5 nmol/L (>145 ng/dL), this suggests possible neoplasm and requires:
- Transvaginal ultrasound for ovarian pathology 2, 4
- CT scan of adrenals 2
- DHEAS to assess adrenal contribution 3
The most common cause in postmenopausal women is polycystic ovary syndrome (PCOS) persisting from reproductive years 1, 2. However, ovarian hyperthecosis, Leydig cell tumors, and adrenal tumors must be excluded, particularly with severe hyperandrogenism 5, 4.
Treatment Algorithm
For Cosmetic Management (All Patients)
Laser photoepilation is superior to all other hair removal methods 3:
- Reduces hair counts by 74% vs. 35% with electrolysis 3
- 60 times faster than electrolysis (30 seconds vs. 30 minutes per treatment) 3
- Less painful and more efficient 3
- Use alexandrite, Nd:YAG, or diode lasers depending on skin type 3
- For dark skin, use longer wavelength Nd:YAG laser 3
Add topical eflornithine cream 13.9% (Vaniqa) 3:
- Slows hair growth rate (does not remove hair)
- Results visible in 6-8 weeks 3
- Can be used alone or combined with laser for enhanced effect 3
- When combined with laser, produces better results than laser alone 3
- Side effects minimal: itching and dry skin 3
For Underlying Androgen Excess
If androgen-secreting tumor identified:
- Bilateral salpingo-oophorectomy is the definitive treatment 5, 2, 4
- Unilateral surgery may leave residual disease 5
- Surgery normalizes testosterone and improves glycemic control in diabetic patients 6, 4
If functional hyperandrogenism (PCOS, hyperthecosis) without tumor:
- Antiandrogens are appropriate for symptom control 3, 1
- Spironolactone 100 mg/d is effective (though guidelines are for premenopausal women, the mechanism applies) 3
- GnRH analogs can control gonadal hyperandrogenism 1, 7
- Low-dose glucocorticoids for adrenal functional hyperandrogenism 1
Critical Pitfalls to Avoid
- Do not dismiss postmenopausal hirsutism as "normal aging" 6 - it requires evaluation
- Do not perform unilateral oophorectomy - bilateral surgery is needed to prevent residual disease 5
- Do not delay imaging if testosterone >5 nmol/L - tumor risk is significant 1, 2
- Do not expect immediate results from any pharmacological therapy - allow at least 6 months trial before changing treatment 3
- Hair growth cycles are 4 months for facial hair - cosmetic improvements take 6-9 months to become maximal 3
Important Nuances
The evidence base is primarily from premenopausal guidelines [3-3, but the treatment principles for cosmetic management apply universally. Recent research [1-7 emphasizes that postmenopausal hyperandrogenism has distinct considerations, particularly the higher index of suspicion for neoplasm.
Electrolysis remains an option for small areas or when laser is contraindicated (very light hair, any skin color tolerated), but it is significantly more time-consuming and painful 3.
Temporary methods (shaving, waxing, bleaching) are safe but require frequent repetition and do not address the underlying problem 3.